FindTrial
Sign In

An Effective Dose Study of Esketamine Combined with Propofol in inhibiting body movement when patients undergoing hysteroscopy

An Effective Dose Study of Esketamine Combined with Propofol in inhibiting body movement when patients undergoing hysteroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079831
Enrollment
Unknown
Registered
2024-01-13
Start date
2021-12-01
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopy

Interventions

Experimental group:The dosage of eschloramine was determined using Dixon's up and down sequential method. Set the initial dose of eschloramide to 0.5 mg/kg. If the patient experiences a negative react

Sponsors

Haikou Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: ASA classification I to II, female, age 18 to 60 years old, and no history of vaginal delivery.

Exclusion criteria

Exclusion criteria: The exclusion criteria included hepatitis and renal failure, habitual sedative or analgesic use, mental illness, and allergy to esketamine or propofol.

Design outcomes

Primary

MeasureTime frame
Body movement ;—

Secondary

MeasureTime frame
Heart Rate;Mean Arterial Pressure;Blood Oxygen Saturation ;—

Countries

China

Contacts

Public ContactShuangfeng Li

Haikou Maternal and Child Health Hospital

e-lishuangfeng1984@126.com+86 152 8985 8386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026